Stifel downgraded Staar Surgical (STAA) to Hold from Buy with a price target of $28, up from $20, following the proposed acquisition by Alcon (ALC). The acquisition makes sense strategically and the valuation paid appears attractive for Alcon, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA: